Promising New Era in Hepatitis C Treatment Medscape In a phase 2 trial of 61 patients infected with hepatitis C who were awaiting liver transplantation, 37 had an undetectable viral load (<25 IU/mL) after 48 weeks of treatment with sofosbuvir and ribavirin. Of those, 62% had an undetectable viral load ... |
